CAS 143868-20-6

galanin (1-13)-spantide I

Description:

Galanin (1-13)-spantide I is a synthetic peptide that combines elements of galanin, a neuropeptide involved in various physiological processes, with spantide I, which is known for its antagonistic properties against certain receptors. This compound is characterized by its specific amino acid sequence, which influences its biological activity and receptor binding affinity. Galanin itself plays a role in modulating neurotransmission, pain perception, and neuroendocrine functions, while spantide I is recognized for its ability to inhibit the action of neurokinin receptors. The unique combination of these two components in galanin (1-13)-spantide I suggests potential applications in research related to neurobiology and pharmacology, particularly in understanding pain mechanisms and neuropeptide signaling pathways. Its CAS number, 143868-20-6, serves as a unique identifier for this compound in chemical databases, facilitating its study and application in various scientific fields. As with many peptides, stability, solubility, and bioavailability are important characteristics that influence its practical use in research and therapeutic contexts.

Formula: C₁₃₈H₁₉₉N₃₅O₃₀

InChI: InChI=1/C138H199N35O30/c1-72(2)54-96(161-122(188)97(55-73(3)4)162-125(191)101(60-80-41-43-84(176)44-42-80)155-114(181)69-151-117(183)77(11)153-131(197)106(71-174)168-127(193)105(64-112(144)179)166-124(190)99(57-75(7)8)167-135(201)116(78(12)175)169-128(194)102(154-113(180)65-140)61-81-66-148-89-33-19-16-30-85(81)89)119(185)152-70-115(182)171-51-25-38-107(171)132(198)159-95(37-24-50-147-138(145)146)137(203)173-53-27-40-109(173)134(200)158-94(36-22-23-49-139)136(202)172-52-26-39-108(172)133(199)157-93(46-48-111(143)178)120(186)156-92(45-47-110(142)177)121(187)165-104(63-83-68-150-91-35-21-18-32-87(83)91)130(196)170-129(195)100(58-76(9)10)164-123(189)98(56-74(5)6)163-126(192)103(62-82-67-149-90-34-20-17-31-86(82)90)160-118(184)88(141)59-79-28-14-13-15-29-79/h13-21,28-35,41-44,66-68,72-78,88,92-109,116,148-150,174-176H,22-27,36-40,45-65,69-71,139-141H2,1-12H3,(H2,142,177)(H2,143,178)(H2,144,179)(H,151,183)(H,152,185)(H,153,197)(H,154,180)(H,155,181)(H,156,186)(H,157,199)(H,158,200)(H,159,198)(H,160,184)(H,161,188)(H,162,191)(H,163,192)(H,164,189)(H,165,187)(H,166,190)(H,167,201)(H,168,193)(H,169,194)(H4,145,146,147)(H,170,195,196)/t77-,78+,88-,92-,93-,94-,95+,96-,97-,98-,99-,100-,101-,102-,103+,104+,105-,106-,107-,108-,109-,116-/m0/s1

Synonyms:

• H-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-D-Arg-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2

Galanin (1-13)-Spantide I

CAS: 143868-20-6

Spantide I is a peptide that is a member of the Galanin family. It has been shown to have a proliferative effect on retinal cells in vitro, and may be effective in treating diabetic retinopathy. Spantide I also inhibits the production of pancreatic enzymes and choroidal neovascularization. It is a diagnostic marker for cancer and other diseases, as well as being used in the treatment of hepatitis. The sequences for Spantide I are GG-S-P-A-N-T-I-D-E--I--H--Gly--Trp--Thr--Leu--Asn--Ser--Ala--Gly--Tyr--Leu--Leu---Gly---Pro---D----Arg---Pro-----Lys---Pro-------Gln-------D------Trp------Phe------D------Trp------Leu-------Leu-----NH2

Formula: C₁₃₈H₁₉₉N₃₅O₃₀

Purity: Min. 95%

Molecular weight: 2,828.27 g/mol

Ref: 3D-FG108716